NEW YORK GENOME CENTER, INC.

New York Genome Center, Inc. specializes in large-scale genomic sequencing and high-throughput omics analysis for federal research and precision medicine initiatives. Their core capabilities include whole exome and RNA sequencing using next-generation platforms, centralized omics data generation, and bioinformatics support for complex biological datasets. They deliver end-to-end genome characterization services for large consortia, with deep expertise in transcriptomics, single-cell analysis, and genomic data integration for neuroscientific and translational research. Their technical differentiation lies in operationalizing high-complexity sequencing pipelines at scale, supporting mission-critical programs requiring rigorous data quality, reproducibility, and compliance with federal research standards. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, particularly through the National Heart, Lung, and Blood Institute, where they serve as a centralized sequencing core for the Trans-Omics for Precision Medicine initiative. They also provide critical sequencing infrastructure to the Department of Veterans Affairs for ongoing biomedical research studies, consistently supporting genome-wide analyses in clinical and population health contexts. Their primary focus is in biotechnology research and development (NAICS 541714) and testing laboratory services (541380), positioning them as a specialized provider of genomic infrastructure for public health and life sciences research. They operate at the intersection of academic discovery and federal program execution, serving as a trusted technical partner for large-scale genomic data generation in precision medicine and brain science initiatives. As a non-profit research institution based in New York, NY, the organization operates under an 8H entity structure with no formal government certifications. Their market positioning is defined by scientific rigor, technical scalability in genomic data production, and deep integration into federally funded research networks.